{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:31:32Z","timestamp":1794281492709,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Post-COVID-19 syndrome (PCS) may vary across pandemic phases. We compared the prevalence of post-acute COVID-19 symptom clusters following SARS-CoV-2 infection in the early pandemic and during the Omicron era using a population-based approach. The EPILOC study enrolled individuals aged 18\u201365\u00a0years who tested PCR-positive for SARS-CoV-2 during the early pandemic, between October 2020 and April 2021, in defined geographic regions within Baden-W\u00fcrttemberg. EPILOC-Omicron used an identical design for individuals infected between June and July 2022. Participants completed a standardised questionnaire assessing sociodemographics, lifestyle, symptoms, and health-related quality of life (SF-12). PCS was defined as\u2009\u2264\u200980% recovery of general health or work capacity plus at least one new moderate-to-strong symptom, both compared to before index infection. Generalised linear models adjusted for age, sex, and education were used to estimate relative risks (RRs). We analysed data from 11,710 EPILOC (24% response) and 12,560 EPILOC-Omicron participants (17% response). Participants were similar in age and sex distribution. Vaccination before infection differed markedly (&lt;\u20093 vs.\u2009&gt;\u200992%). PCS prevalence was 29.6% in EPILOC and 14.5% in EPILOC-Omicron. Predictors of PCS were similar for both. Symptom clusters were consistently less frequent after infection during the Omicron era (e.g., fatigue RR\u2009=\u20090.54; neurocognitive impairment RR\u2009=\u20090.53; chest symptoms RR\u2009=\u20090.47; smell\/taste disorder RR\u2009=\u20090.17). Health-related quality of life was similar in PCS cases of both cohorts (mean SF-12\n                    <jats:sub>Physical<\/jats:sub>\n                    40.3 vs. 41.0, mean SF-12\n                    <jats:sub>Mental<\/jats:sub>\n                    38.9 vs. 40.7). PCS was less common following SARS-CoV-2 infection in the Omicron era compared to the early pandemic period. However, affected individuals continue to experience substantial, comparable impairment in hrQoL across both pandemic periods.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-52945-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:15:34Z","timestamp":1779218134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Population-based comparison of post-acute sequelae of COVID-19 and health-related quality of life across pandemic periods: Omicron era versus early pandemic"],"prefix":"10.1038","volume":"16","author":[{"given":"Raphael S.","family":"Peter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Nieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisamaria","family":"Sedelmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Kr\u00e4usslich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen M.","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Rothenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the EPILOC Omicron Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Blankenhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Bopp-Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Braig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Conzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Deibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Friedmann-Bette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Grote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Junginger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Matits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Niess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolde","family":"Piechotowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"R\u00f6ttele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Schellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Schwertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Spannenkrebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Walter-Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kersten","family":"Wolfers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"52945_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012328","author":"P Relan","year":"2023","unstructured":"Relan, P. et al. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: A systematic review and metanalysis. BMJ Glob. Health https:\/\/doi.org\/10.1136\/bmjgh-2023-012328 (2023).","journal-title":"BMJ Glob. Health"},{"key":"52945_CR2","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S. & Steves, C. J. Risk of long COVID associated with Delta versus Omicron variants of SARS-CoV-2. Lancet 399, 2263\u20132264. https:\/\/doi.org\/10.1016\/S0140-6736(22)00941-2 (2022).","journal-title":"Lancet"},{"key":"52945_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1056\/NEJMoa2403211","volume":"391","author":"Y Xie","year":"2024","unstructured":"Xie, Y., Choi, T. & Al-Aly, Z. Postacute sequelae of SARS-CoV-2 infection in the Pre-Delta, Delta, and Omicron eras. N. Engl. J. Med. 391, 515\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2403211 (2024).","journal-title":"N. Engl. J. Med."},{"key":"52945_CR4","doi-asserted-by":"publisher","first-page":"110507","DOI":"10.1016\/j.clim.2025.110507","volume":"278","author":"V Vacharathit","year":"2025","unstructured":"Vacharathit, V. et al. Persistent IP-10\/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes. Clin. Immunol. 278, 110507. https:\/\/doi.org\/10.1016\/j.clim.2025.110507 (2025).","journal-title":"Clin. Immunol."},{"key":"52945_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.35772\/ghm.2022.01069","volume":"4","author":"X Liao","year":"2022","unstructured":"Liao, X. et al. Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant. Glob. Health Med. 4, 322\u2013326. https:\/\/doi.org\/10.35772\/ghm.2022.01069 (2022).","journal-title":"Glob. Health Med."},{"key":"52945_CR6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.jiac.2022.08.007","volume":"28","author":"S Morioka","year":"2022","unstructured":"Morioka, S. et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J. Infect. Chemother. 28, 1546\u20131551. https:\/\/doi.org\/10.1016\/j.jiac.2022.08.007 (2022).","journal-title":"J. Infect. Chemother."},{"key":"52945_CR7","doi-asserted-by":"publisher","first-page":"104688","DOI":"10.1016\/j.idnow.2023.104688","volume":"53","author":"A Hern\u00e1ndez-Aceituno","year":"2023","unstructured":"Hern\u00e1ndez-Aceituno, A., Garc\u00eda-Hern\u00e1ndez, A. & Larumbe-Zabala, E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect. Dis. Now 53, 104688. https:\/\/doi.org\/10.1016\/j.idnow.2023.104688 (2023).","journal-title":"Infect. Dis. Now"},{"key":"52945_CR8","doi-asserted-by":"publisher","first-page":"e071050","DOI":"10.1136\/bmj-2022-071050","volume":"379","author":"RS Peter","year":"2022","unstructured":"Peter, R. S. et al. Post-acute sequelae of COVID-19 six to 12 months after infection: Population based study. BMJ 379, e071050. https:\/\/doi.org\/10.1136\/bmj-2022-071050 (2022).","journal-title":"BMJ"},{"key":"52945_CR9","doi-asserted-by":"publisher","first-page":"e1004511","DOI":"10.1371\/journal.pmed.1004511","volume":"22","author":"RS Peter","year":"2025","unstructured":"Peter, R. S. et al. Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19\/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study. PLoS Med. 22, e1004511. https:\/\/doi.org\/10.1371\/journal.pmed.1004511 (2025).","journal-title":"PLoS Med."},{"key":"52945_CR10","doi-asserted-by":"publisher","first-page":"101549","DOI":"10.1016\/j.eclinm.2022.101549","volume":"51","author":"T Bahmer","year":"2022","unstructured":"Bahmer, T. et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine 51, 101549. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101549 (2022).","journal-title":"EClinicalMedicine"},{"key":"52945_CR11","doi-asserted-by":"publisher","unstructured":"Robert-Koch-Institut. SARS-CoV-2 Sequenzdaten aus Deutschland 2025. https:\/\/doi.org\/10.5281\/zenodo.15640795","DOI":"10.5281\/zenodo.15640795"},{"key":"52945_CR12","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/cid\/ciac613","volume":"76","author":"KD Vihta","year":"2022","unstructured":"Vihta, K. D. et al. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 76, e133-141. https:\/\/doi.org\/10.1093\/cid\/ciac613 (2022).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"52945_CR13","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1017\/S0950268822001297","volume":"150","author":"AKE Ekroth","year":"2022","unstructured":"Ekroth, A. K. E., Patrzylas, P., Turner, C., Hughes, G. J. & Anderson, C. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England. Epidemiol. Infect. 150, e162. https:\/\/doi.org\/10.1017\/S0950268822001297 (2022).","journal-title":"Epidemiol. Infect."},{"key":"52945_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/ohn.384","volume":"169","author":"ER Reiter","year":"2023","unstructured":"Reiter, E. R., Coelho, D. H., French, E., Costanzo, R. M., Consortium N. COVID-19-associated chemosensory loss continues to decline. Otolaryngol. Head Neck Surg. 169, 1386\u20131389. https:\/\/doi.org\/10.1002\/ohn.384 (2023).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"52945_CR15","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S1473-3099(23)00271-2","volume":"23","author":"S Nakakubo","year":"2023","unstructured":"Nakakubo, S. et al. Associations of COVID-19 symptoms with Omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: A registry-based observational study. Lancet Infect. Dis. 23, 1244\u20131256. https:\/\/doi.org\/10.1016\/S1473-3099(23)00271-2 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"52945_CR16","doi-asserted-by":"publisher","first-page":"e0281429","DOI":"10.1371\/journal.pone.0281429","volume":"18","author":"T Ballouz","year":"2023","unstructured":"Ballouz, T. et al. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts. PLoS One 18, e0281429. https:\/\/doi.org\/10.1371\/journal.pone.0281429 (2023).","journal-title":"PLoS ONE"},{"key":"52945_CR17","doi-asserted-by":"publisher","first-page":"e076990","DOI":"10.1136\/bmj-2023-076990","volume":"383","author":"L Lundberg-Morris","year":"2023","unstructured":"Lundberg-Morris, L. et al. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: Population based cohort study. BMJ 383, e076990. https:\/\/doi.org\/10.1136\/bmj-2023-076990 (2023).","journal-title":"BMJ"},{"key":"52945_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf549","author":"S Carazo","year":"2025","unstructured":"Carazo, S. et al. Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaf549 (2025).","journal-title":"Clin. Infect. Dis."},{"key":"52945_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2023.08.019","volume":"136","author":"S Diexer","year":"2023","unstructured":"Diexer, S. et al. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 136, 14\u201321. https:\/\/doi.org\/10.1016\/j.ijid.2023.08.019 (2023).","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"52945_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/infdis\/jiad382","volume":"229","author":"P Hedberg","year":"2024","unstructured":"Hedberg, P. & Naucl\u00e9r, P. Post-COVID-19 condition after SARS-CoV-2 infections during the Omicron surge vs the Delta, Alpha, and wild type periods in Stockholm, Sweden. J. Infect. Dis. 229, 133\u2013136. https:\/\/doi.org\/10.1093\/infdis\/jiad382 (2024).","journal-title":"J. Infect. Dis."},{"key":"52945_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12995-024-00431-8","volume":"19","author":"T Barnekow","year":"2024","unstructured":"Barnekow, T., Peters, C., Dulon, M. & Nienhaus, A. Impact of pre-existing conditions on the severity of post-COVID syndrome among workers in healthcare and social services in Germany. J. Occup. Med. Toxicol. 19, 32. https:\/\/doi.org\/10.1186\/s12995-024-00431-8 (2024).","journal-title":"J. Occup. Med. Toxicol."},{"key":"52945_CR22","doi-asserted-by":"publisher","DOI":"10.3201\/eid3007.231723","author":"A Iba","year":"2024","unstructured":"Iba, A. et al. Prevalence of and risk factors for Post\u2013COVID-19 condition during Omicron BA.5\u2013Dominant Wave, Japan. Emerg. Infect. D. J. - CDC https:\/\/doi.org\/10.3201\/eid3007.231723 (2024).","journal-title":"Emerg. Infect. D. J. - CDC"},{"key":"52945_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amjmed.2024.02.010","volume":"138","author":"SS Hejazian","year":"2025","unstructured":"Hejazian, S. S. et al. Prevalence and determinants of long-term post-COVID conditions in the United States: 2022 behavioral risk factor surveillance system. Am. J. Med. 138, 513-523.e10. https:\/\/doi.org\/10.1016\/j.amjmed.2024.02.010 (2025).","journal-title":"Am. J. Med."},{"key":"52945_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0750","author":"V Tsampasian","year":"2023","unstructured":"Tsampasian, V. et al. Risk factors associated with post\u2212COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2023.0750 (2023).","journal-title":"JAMA Intern. Med."},{"key":"52945_CR25","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/BRS.0000000000002298","volume":"42","author":"MJ D\u00edaz-Arribas","year":"2017","unstructured":"D\u00edaz-Arribas, M. J. et al. Minimal clinically important difference in quality of life for patients with low back pain. Spine 42, 1908. https:\/\/doi.org\/10.1097\/BRS.0000000000002298 (2017).","journal-title":"Spine"},{"key":"52945_CR26","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1183\/09031936.00153712","volume":"42","author":"C Janson","year":"2013","unstructured":"Janson, C. et al. The impact of COPD on health status: Findings from the BOLD study. Eur. Respir. J. 42, 1472\u20131483. https:\/\/doi.org\/10.1183\/09031936.00153712 (2013).","journal-title":"Eur. Respir. J."},{"key":"52945_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4088\/JCP.09m05094blu","volume":"72","author":"JS Comer","year":"2011","unstructured":"Comer, J. S. et al. Health-related quality of life across the anxiety disorders. J. Clin. Psychiatr. 72, 43\u201350. https:\/\/doi.org\/10.4088\/JCP.09m05094blu (2011).","journal-title":"J. Clin. Psychiatr."},{"key":"52945_CR28","doi-asserted-by":"publisher","first-page":"e0292928","DOI":"10.1371\/journal.pone.0292928","volume":"18","author":"S Beyer","year":"2023","unstructured":"Beyer, S. et al. Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life. PLoS ONE 18, e0292928. https:\/\/doi.org\/10.1371\/journal.pone.0292928 (2023).","journal-title":"PLoS ONE"},{"key":"52945_CR29","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s15010-024-02270-5","volume":"52","author":"SM Hopff","year":"2024","unstructured":"Hopff, S. M. et al. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants Delta and Omicron\u2014Results of the cross-sectoral platform of the German National Pandemic Cohort Network (NAPKON-SUEP). Infection 52, 2253\u20132267. https:\/\/doi.org\/10.1007\/s15010-024-02270-5 (2024).","journal-title":"Infection"},{"key":"52945_CR30","doi-asserted-by":"publisher","first-page":"ofaf142","DOI":"10.1093\/ofid\/ofaf142","volume":"12","author":"BP Jacka","year":"2025","unstructured":"Jacka, B. P. et al. Trajectories of health-related quality of life 2 years after mild\/moderate severe acute respiratory syndrome coronavirus 2 infection in the pre-Omicron era. Open Forum Infect. Dis. 12, ofaf142. https:\/\/doi.org\/10.1093\/ofid\/ofaf142 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"52945_CR31","doi-asserted-by":"publisher","first-page":"106500","DOI":"10.1016\/j.jinf.2025.106500","volume":"90","author":"RS Peter","year":"2025","unstructured":"Peter, R. S. et al. Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study. J. Infect. 90, 106500. https:\/\/doi.org\/10.1016\/j.jinf.2025.106500 (2025).","journal-title":"J. Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52945-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52945-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:19:46Z","timestamp":1779218386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52945-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52945-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15603"}}